首页 | 本学科首页   官方微博 | 高级检索  
     


Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
Affiliation:1. Catholic University of the Sacred Heart and A. Gemelli Teaching Hospital Foundation, Rome, Italy;2. AstraZeneca, Alderley Park, Macclesfield, UK;3. Fundación Instituto Valenciano de Oncología, València, Spain;4. Departement de Pathologie, Centre Jean Perrin; INSERM UMR 1240, Clermont-Ferrand, France;5. Radboud University Medical Center, Nijmegen, Netherlands;6. The Royal Marsden NHS Foundation Trust, London, UK;7. Medical University of Vienna, Vienna, Austria;8. Sheba Medical Center, Tel Hashomer, Israel;9. University of Cologne, Cologne, Germany;10. University Hospital Heidelberg, Germany;11. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands;12. Claude Bernard University, Lyon, France;13. Princess Margaret Cancer Centre, Toronto, Canada;14. Nazionale Tumori IRCCS Pascale, Naples, Italy;15. Kantonsspital Aarau, Aarau, Switzerland;p. University of Singapore, Singapore;q. Queen’s University Belfast, Belfast, UK
Abstract:
Keywords:Ovarian cancer  BRCA1  BRCA2  Tumor testing
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号